Uncovering accurate prognostic markers for high‐risk uveal melanoma through DNA methylation profiling
Clinical and Translational Medicine · 2023
DOI: 10.1002/ctm2.1317 ↗Kurz gefasst
Leserbrief in der Zeitschrift Clinical and Translational Medicine, 2023. Verfasst von Andrea Soltysova und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology, Faculty of Natural Sciences, Comenius University in Bratislava, Bratislava, Slovakia. Hauptthemen laut MEDLINE: Melanoma, Uveal Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Molecular Biology, Faculty of Natural Sciences, Comenius University in Bratislava, Bratislava, Slovakia.
- Institute for Clinical and Translational Research, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia.
- Biomedical Centre Martin, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Martin, Slovakia.
- Department of Molecular Oncology, Cancer Research Institute, Biomedical Research Center of the Slovak Academy of Sciences, Bratislava, Slovakia.
- Department of Pathology, Faculty of Medicine, Comenius University in Bratislava, Bratislava, Slovakia.
- Lambda Life a.s., Bratislava, Slovakia.
ORCID-Profile: Bozena Smolkova
Zitieren
APA
Soltysova, A., Dvorska, D., Kajabova, V. H., Pecimonova, M., Cepcekova, K., Ficek, A., Demkova, L., Buocikova, V., Babal, P., Juras, I., Janikova, K., Kasubova, I., Samec, M., Brany, D., Lyskova, D., Valaskova, J., Dankova, Z., Smolkova, B., & Furdova, A. (2023). Uncovering accurate prognostic markers for high‐risk uveal melanoma through DNA methylation profiling. Clinical and Translational Medicine. https://doi.org/10.1002/ctm2.1317
Vancouver
Soltysova A, Dvorska D, Kajabova VH, Pecimonova M, Cepcekova K, Ficek A, et al. Uncovering accurate prognostic markers for high‐risk uveal melanoma through DNA methylation profiling. Clinical and Translational Medicine. 2023. doi:10.1002/ctm2.1317
BibTeX
@article{Soltysova2023,
author = {Soltysova, Andrea and Dvorska, Dana and Kajabova, Viera Horvathova and Pecimonova, Martina and Cepcekova, Klaudia and Ficek, Andrej and Demkova, Lucia and Buocikova, Verona and Babal, Pavel and Juras, Ivan and Janikova, Katarina and Kasubova, Ivana and Samec, Marek and Brany, Dusan and Lyskova, Darina and Valaskova, Jela and Dankova, Zuzana and Smolkova, Bozena and Furdova, Alena},
title = {Uncovering accurate prognostic markers for high‐risk uveal melanoma through DNA methylation profiling},
journal = {Clinical and Translational Medicine},
year = {2023},
doi = {10.1002/ctm2.1317}
}
EUVIMED